[Efficacy and safety of autologous hematopoietic stem cell transplantation pretreated with Melphalan hydrochloride for injection in the treatment of 125 cases of multiple myeloma].
作者信息
Huang W Y, Liu W, Liu H M, Xu Y, Wang Q, Du C X, Xiong W J, Sui W W, Tian F, Wang J, Yi S H, An G, Qiu L G, Zou D H
机构信息
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):148-150. doi: 10.3760/cma.j.issn.0253-2727.2023.02.011.
Abstract
摘要
相似文献
1
[Efficacy and safety of autologous hematopoietic stem cell transplantation pretreated with Melphalan hydrochloride for injection in the treatment of 125 cases of multiple myeloma].注射用美法仑预处理自体造血干细胞移植治疗125例多发性骨髓瘤的疗效与安全性
Zhonghua Xue Ye Xue Za Zhi. 2023 Feb 14;44(2):148-150. doi: 10.3760/cma.j.issn.0253-2727.2023.02.011.
2
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.一项关于注射用高剂量、无丙二醇美法仑（EVOMELA）用于接受自体移植的多发性骨髓瘤患者清髓预处理的IIb期、多中心、开放标签、安全性和有效性研究。
Biol Blood Marrow Transplant. 2015 Dec;21(12):2100-2105. doi: 10.1016/j.bbmt.2015.08.026. Epub 2015 Aug 29.
3
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma.静脉注射白消安加美法仑与单独使用美法仑作为多发性骨髓瘤患者的预处理方案比较。
Ann Hematol. 2019 Aug;98(8):2013-2015. doi: 10.1007/s00277-019-03663-5. Epub 2019 Mar 16.
4
Optimal dosing of melphalan as high-dose therapy before autologous hematopoietic stem cell transplantation in myeloma patients with solitary kidney: a case series.骨髓瘤合并孤立肾患者自体造血干细胞移植前美法仑高剂量治疗的最佳剂量：病例系列
Clin Lymphoma Myeloma Leuk. 2014 Apr;14(2):e59-63. doi: 10.1016/j.clml.2013.11.007. Epub 2013 Nov 15.
5
Melphalan-based autologous transplant in octogenarian multiple myeloma patients.基于美法仑的自体移植用于八旬多发性骨髓瘤患者。
Am J Hematol. 2019 Jan;94(1):E2-E5. doi: 10.1002/ajh.25310. Epub 2018 Oct 31.
6
The role of transplant in multiple myeloma.移植在多发性骨髓瘤中的作用。
Clin Adv Hematol Oncol. 2005 Aug;3(8):604-6.
7
Autologous hematopoietic stem-cell transplantation for multiple myeloma.多发性骨髓瘤的自体造血干细胞移植
N Engl J Med. 2009 Jun 18;360(25):2645-54. doi: 10.1056/NEJMct0805626.
8
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma.一项关于苯达莫司汀和马法兰预处理用于多发性骨髓瘤自体干细胞移植的 1 期研究。
Biol Blood Marrow Transplant. 2013 May;19(5):831-7. doi: 10.1016/j.bbmt.2013.02.013. Epub 2013 Feb 20.
9
Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.美法仑剂量强度在多发性骨髓瘤自体干细胞移植中的应用
Haematologica. 2021 Dec 1;106(12):3211-3214. doi: 10.3324/haematol.2021.279179.
10
Tandem bone marrow transplantation in multiple myeloma.多发性骨髓瘤的串联骨髓移植
N Engl J Med. 2004 Apr 1;350(14):1466-7; author reply 1466-7.
本文引用的文献
1
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.美国国立综合癌症网络（NCCN）指南见解：多发性骨髓瘤，2022年第3版
J Natl Compr Canc Netw. 2022 Jan;20(1):8-19. doi: 10.6004/jnccn.2022.0002.
2
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.多发性骨髓瘤：欧洲血液学协会-欧洲肿瘤内科学会诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Mar;32(3):309-322. doi: 10.1016/j.annonc.2020.11.014. Epub 2021 Feb 3.
3
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma.无丙二醇马法兰与 PG-马法兰作为骨髓瘤自体造血细胞移植预处理方案的比较。
Biol Blood Marrow Transplant. 2020 Dec;26(12):2229-2236. doi: 10.1016/j.bbmt.2020.08.030. Epub 2020 Sep 11.
4
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myeloma.在多发性骨髓瘤的自体干细胞移植中使用不含丙二醇的美法仑，可获得可比的结果。
Bone Marrow Transplant. 2019 Apr;54(4):587-594. doi: 10.1038/s41409-018-0302-6. Epub 2018 Aug 16.
5
Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.卡培他滨稳定的美法仑（依维莫司）与丙二醇基盐酸美法仑注射液的稳定性比较。
Pharm Dev Technol. 2018 Dec;23(10):1024-1029. doi: 10.1080/10837450.2016.1265557. Epub 2016 Dec 14.
6
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.国际骨髓瘤工作组多发性骨髓瘤反应和微小残留病评估的共识标准。
Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.
7
A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.一项关于注射用高剂量、无丙二醇美法仑（EVOMELA）用于接受自体移植的多发性骨髓瘤患者清髓预处理的IIb期、多中心、开放标签、安全性和有效性研究。
Biol Blood Marrow Transplant. 2015 Dec;21(12):2100-2105. doi: 10.1016/j.bbmt.2015.08.026. Epub 2015 Aug 29.
8
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.多发性骨髓瘤修订国际分期系统：国际骨髓瘤工作组报告
J Clin Oncol. 2015 Sep 10;33(26):2863-9. doi: 10.1200/JCO.2015.61.2267. Epub 2015 Aug 3.
9
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
10
Phase IIa cross-over study of propylene glycol-free melphalan (LGD-353) and alkeran in multiple myeloma autologous transplantation.无丙二醇美法仑（LGD - 353）与左旋苯丙氨酸氮芥用于多发性骨髓瘤自体移植的IIa期交叉研究。
Bone Marrow Transplant. 2014 Aug;49(8):1042-5. doi: 10.1038/bmt.2014.120. Epub 2014 Jun 9.
Zotero 插件